EFFECT OF MEAL SIZE AND COMPOSITION ON THE BIOAVAILABILITY OF KETOPROFEN (ORUVAIL)

被引：8

作者：

NIEVEL, JG ^{[1
]}

HAVARD, CWH ^{[1
]}

MITCHELL, P ^{[1
]}

GUDGEON, A ^{[1
]}

KAYE, CM ^{[1
]}

机构：

[1] MAY & BAKER LTD,DAGENHAM RM10 7XS,ESSEX,ENGLAND

来源：

XENOBIOTICA | 1987年 / 17卷 / 04期

关键词：

D O I：

10.3109/00498258709043955

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：487 / 492

页数：6

共 10 条

[1] INFLUENCE OF FOOD ON THE ABSORPTION OF ACETYLSALICYLIC-ACID FROM ENTERIC-COATED DOSAGE FORMS [J].

BOGENTOFT, C ;

CARLSSON, I ;

EKENVED, G ;

MAGNUSSON, A .

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1978, 14 (05) :351-355

[2] KETOPROFEN - PRELIMINARY REPORT OF ITS PHARMACOLOGICAL ACTIVITY AND THERAPEUTIC EFFICACY IN RHEUMATIC DISORDERS [J].

BROGDEN, RN ;

SPEIGHT, TM ;

AVERY, GS .

DRUGS, 1974, 8 (03) :168-175

[3] A COMPARATIVE-STUDY OF THE GASTROINTESTINAL TRANSIT OF A PELLET AND TABLET FORMULATION [J].

DAVIS, SS ;

HARDY, JG ;

TAYLOR, MJ ;

WHALLEY, DR ;

WILSON, CG .

INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1984, 21 (02) :167-177

[4]

GREGOIRE J, 1977, 14TH INT C RHEUM SAN, P72

[5]

HOLT JE, 1983, BRIT J PHARM, V80, pP533

[6]

HOUGHTON GW, 1984, INT J CLIN PHARM TH, V22, P131

[7] COMPARATIVE PHARMACOKINETICS OF KETOPROFEN DERIVED FROM SINGLE ORAL DOSES OF KETOPROFEN CAPSULES OR A NOVEL SUSTAINED-RELEASE PELLET FORMULATION [J].

HOUGHTON, GW ;

DENNIS, MJ ;

RIGLER, ED ;

PARSONS, RL .

BIOPHARMACEUTICS & DRUG DISPOSITION, 1984, 5 (03) :203-209

[8] A HIGH-PRESSURE LIQUID-CHROMATOGRAPHIC METHOD FOR THE ASSAY OF KETOPROFEN IN PLASMA AND URINE, AND ITS APPLICATION TO DETERMINING THE URINARY-EXCRETION OF FREE AND CONJUGATED KETOPROFEN FOLLOWING ORAL-ADMINISTRATION OF ORUDIS TO MAN [J].

KAYE, CM ;

SANKEY, MG ;

HOLT, JE .

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1981, 11 (04) :395-398

[9]

SKINHOJ A, 1984, INT J CLIN PHARM TH, V22, P557

[10]

WELLING P G, 1983, Drug-Nutrient Interactions, V2, P153

← 1 →